214 related articles for article (PubMed ID: 9746591)
41. Immune responses of different mouse strains after challenge with equivalent lethal doses of Toxoplasma gondii.
Lee YH; Kasper LH
Parasite; 2004 Mar; 11(1):89-97. PubMed ID: 15071833
[TBL] [Abstract][Full Text] [Related]
42. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1.
Mishima M; Xuan X; Shioda A; Omata Y; Fujisaki K; Nagasawa H; Mikami T
J Vet Med Sci; 2001 Apr; 63(4):433-8. PubMed ID: 11346179
[TBL] [Abstract][Full Text] [Related]
43. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of protective immunity induced by recombinant calcium-dependent protein kinase 1 (TgCDPK1) protein against acute toxoplasmosis in mice.
Huang SY; Chen K; Wang JL; Yang B; Zhu XQ
Microb Pathog; 2019 Aug; 133():103560. PubMed ID: 31145981
[TBL] [Abstract][Full Text] [Related]
45. Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.
Dimier-Poisson I; Aline F; Bout D; Mévélec MN
Vaccine; 2006 Mar; 24(10):1705-9. PubMed ID: 16256251
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
Xue M; He S; Cui Y; Yao Y; Wang H
Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
[TBL] [Abstract][Full Text] [Related]
47. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.
Desolme B; Mévélec MN; Buzoni-Gatel D; Bout D
Vaccine; 2000 May; 18(23):2512-21. PubMed ID: 10775785
[TBL] [Abstract][Full Text] [Related]
48. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii.
Lourenço EV; Bernardes ES; Silva NM; Mineo JR; Panunto-Castelo A; Roque-Barreira MC
Microbes Infect; 2006 Apr; 8(5):1244-51. PubMed ID: 16616574
[TBL] [Abstract][Full Text] [Related]
49. DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice.
Wang HL; Wang YJ; Pei YJ; Bai JZ; Yin LT; Guo R; Yin GR
Parasite; 2016; 23():4. PubMed ID: 26842927
[TBL] [Abstract][Full Text] [Related]
50. Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.
Lee YH; Shin DW; Lee JH; Nam HW; Ahn MH
Yonsei Med J; 2007 Jun; 48(3):396-404. PubMed ID: 17594146
[TBL] [Abstract][Full Text] [Related]
51. Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.
Wagner A; Schabussova I; Ruttkowski B; Peschke R; Kur J; Kundi M; Joachim A; Wiedermann U
PLoS One; 2015; 10(5):e0126334. PubMed ID: 26010355
[TBL] [Abstract][Full Text] [Related]
52. Peroxiredoxin 3 promotes IL-12 production from macrophages and partially protects mice against infection with Toxoplasma gondii.
Fereig RM; Nishikawa Y
Parasitol Int; 2016 Dec; 65(6 Pt A):741-748. PubMed ID: 27644889
[TBL] [Abstract][Full Text] [Related]
53. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents.
Angus CW; Klivington-Evans D; Dubey JP; Kovacs JA
J Infect Dis; 2000 Jan; 181(1):317-24. PubMed ID: 10608781
[TBL] [Abstract][Full Text] [Related]
54. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.
Parmley S; Slifer T; Araujo F
J Infect Dis; 2002 Feb; 185 Suppl 1():S90-5. PubMed ID: 11865445
[TBL] [Abstract][Full Text] [Related]
55. Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice.
Fereig RM; Kuroda Y; Terkawi MA; Mahmoud ME; Nishikawa Y
PLoS One; 2017; 12(4):e0176324. PubMed ID: 28448521
[TBL] [Abstract][Full Text] [Related]
56. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii 10 kDa excretory-secretory antigen (TgESA10).
Wang S; Wang Y; Sun X; Zhang Z; Liu T; Gadahi JA; Xu L; Yan R; Song X; Li X
Vet Parasitol; 2015 Nov; 214(1-2):40-8. PubMed ID: 26421596
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
58. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii.
Leyva R; Hérion P; Saavedra R
Parasitol Res; 2001 Jan; 87(1):70-9. PubMed ID: 11199854
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.
Fang R; Feng H; Hu M; Khan MK; Wang L; Zhou Y; Zhao J
Vet Parasitol; 2012 Jun; 187(1-2):140-6. PubMed ID: 22336771
[TBL] [Abstract][Full Text] [Related]
60. A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis.
Ruiz S; Beauvillain C; Mévélec MN; Roingeard P; Breton P; Bout D; Dimier-Poisson I
Cell Microbiol; 2005 Nov; 7(11):1659-71. PubMed ID: 16207252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
